Skip to main content

Advertisement

Log in

Impact of the COVID-19 Pandemic on the PrEP Cascade at Two Veterans Affairs Healthcare Systems

  • Original Paper
  • Published:
AIDS and Behavior Aims and scope Submit manuscript

Abstract

Overall, fewer Veterans were eligible for PrEP in 2020, compared to 2019, and 2018 (Maryland Veterans Affairs Health Care System- MVAHCS-: n = 890 (2020), n = 1533 (2019); Washington DC Veterans Affairs Medical Center -DC VAMC- n = 1119 (2020), n = 1716 (2019)). While the proportion of Veterans engaged in PrEP out of those eligible for PrEP increased in 2020 compared to 2019 at both sites (MVAHCS: 5.73% (2020) vs. 3.39% (2019) p-value = 0.006; F = 7.58, and DC VAMC: 15.91% (2020) vs. 9.38% (2019) p-value < 0.001; F = 27.64), the absolute number of Veterans engaged in PrEP remained unchanged (MVAHCS n = 51 (2020) and n = 52 (2019); DC VAMC n = 178 (2020) and n = 161 (2019)). Engagement in PrEP was significantly lower among Black Veterans compared to White Veterans at the DC VAMC across all FY with a widening gap in 2020. Cisgender women were less likely to be engaged in PrEP compared to cisgender men at both sites and throughout all FY with a wider gender gap in 2020. There were no significant differences in retention in PrEP between FY.

Anticipated improvements in linkage, engagement, and retention in PrEP in 2020 at the MVAHCS and DC VAMC may not have been seen due to the COVID-19 pandemic. Furthermore, engagement rates in PrEP remained low overall, particularly among Black Veterans and cisgender women. Novel PrEP delivery models are needed to engage these populations in PrEP following the COVID-19 pandemic. Interactive dashboards and tele-PrEP may have played a big role in sustained retention in PrEP at the VHA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Dailey A, Gant Z, Li J, Nagaraju S, Elenwa F, Singh S et al. Diagnoses of HIV Infection in the United States and Dependent Areas, 2020 HIV Surveillance Report 2 Vol. 33 [Internet]. 2020. Available from: http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. http://wwwn.cdc.gov/dcs/ContactUs/Form

  2. Accessed. on November 14 2022. https://ahead.hiv.gov/. AHEAD (America’s HIV Epidemic Analysis Dashboard).

  3. Nunn AS, Brinkley-Rubinstein L, Oldenburg CE, Mayer KH, Mimiaga M, Patel R, et al. Defining the HIV pre-exposure prophylaxis care continuum. Volume 31. AIDS. Lippincott Williams and Wilkins; 2017. pp. 731–4.

  4. Robles G, Hong C, Yu M, Starks TJ. Intersecting Communities and PrEP Uptake among US-based latinx sexual minority men. J Racial Ethn Health Disparities. 2021.

  5. Buffel V, Reyniers T, Masquillier C, Thunissen E, Nöstlinger C, Laga M, et al. Awareness of, willingness to take PrEP and its actual use among belgian MSM at high risk of HIV infection: secondary analysis of the belgian european MSM Internet Survey. AIDS Behav. 2022;26(6):1793–807.

    Article  PubMed  Google Scholar 

  6. Marcus JL, Hurley LB, Hare CB, Nguyen DP, Phengrasamy T, Silverberg MJ et al. Preexposure Prophylaxis for HIV Prevention in a large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.

  7. van Epps P, Maier M, Lund B, Bryant Howren M, Beck B, Beste L et al. Medication Adherence in a Nationwide Cohort of Veterans Initiating Pre-exposure Prophylaxis (PrEP) to Prevent HIV Infection [Internet]. 2017. Available from: www.jaids.com.

  8. Gillespie D, Couzens Z, de Bruin M, Hughes DA, Jones A, Ma R et al. PrEP use, sexual Behaviour, and PrEP Adherence among Men who have sex with men living in Wales Prior to and during the COVID-19 pandemic. AIDS Behav. 2022.

  9. Chow EPF, Hocking JS, Ong JJ, Schmidt T, Buchanan A, Rodriguez E et al. Changing the use of HIV preexposure prophylaxis among men who have sex with men during the COVID-19 Pandemic in Melbourne, Australia. Open Forum Infect Dis. 2020;7(7).

  10. Stephenson R, Chavanduka TMD, Rosso MT, Sullivan SP, Pitter RA, Hunter AS, et al. Sex in the Time of COVID-19: results of an online survey of Gay, bisexual and other men who have sex with men’s experience of sex and HIV Prevention during the US COVID-19 Epidemic. AIDS Behav. 2021;25(1):40–8.

    Article  PubMed  Google Scholar 

  11. Hong C, Horvath KJ, Stephenson R, Nelson KM, Petroll AE, Walsh JL, et al. PrEP use and persistence among young sexual minority men 17–24 Years Old during the COVID-19 pandemic. AIDS Behav. 2022;26(3):631–8.

    Article  PubMed  Google Scholar 

  12. Pampati S, Emrick K, Siegler AJ, Jones J. Changes in Sexual Behavior, PrEP Adherence, and Access to Sexual Health Services Because of the COVID-19 Pandemic among a Cohort of PrEP-Using MSM in the South. J Acquir Immune Defic Syndr (1988). 2021;87(1):639–43.

  13. Satcher Johnson A, Gant Z, Huang Y, lin, Smith D, Li J, Hu X et al. Core indicators for monitoring the Ending the HIV Epidemic initiative (preliminary data): National HIV Surveillance System data reported through June 2021; and preexposure prophylaxis (PrEP) data reported through March 2021 [Internet]. Vol. 2. 2021. Available from: http://wwwn.cdc.gov/dcs/ContactUs/Form.

  14. Huang YLA, Zhu W, Wiener J, Kourtis AP, Hall HI, Hoover KW. Impact of Coronavirus Disease 2019 (COVID-19) on human immunodeficiency virus (HIV) pre-exposure Prophylaxis Prescriptions in the United States-A Time-Series Analysis. Clin Infect Dis. 2022;75(1):e1020–7.

    Article  PubMed  Google Scholar 

  15. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC et al. Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data. 2005.

  16. CDC. US Public Health Service: PREEXPOSURE PROPHYLAXIS FOR THE PREVENTION OF HIV INFECTION IN THE UNITED STATES. – 2021 UPDATE, A CLINICAL PRACTICE GUIDELINE. 2021.

  17. Jasuja GK, De Groot A, Quinn EK, Ameli O, Hughto JMW, Dunbar M, et al. Beyond gender identity disorder Diagnoses Codes: an examination of additional methods to identify Transgender individuals in administrative databases. Med Care. 2020;58(10):903–11.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Office of Public and Intergovernmental Affairs. VA health records now display gender identity. 2022.

  19. Gregg E, Linn C, Nace E, Gelberg L, Cowan B, Fulcher JA. Implementation of HIV Preexposure Prophylaxis in a homeless primary care setting at the Veterans Affairs. J Prim Care Community Health. 2020;11:2150132720908370.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Allison KHM, David Malebranche A. Barriers to the Wider Use of Pre-exposure Prophylaxis in the United States: A Narrative Review. Available from: https://doi.org/10.6084/.

  21. Breaux K, Ashong C, Steinberg T, Park Y. Implementation of preventive care in a large urban Veterans Affairs HIV clinic. JAAPA. 2022;35(12):1.

    Article  PubMed  Google Scholar 

  22. Hoth AB, Shafer C, Dillon DB, Mayer R, Walton G, Ohl ME. Iowa TelePrEP: a public-health-partnered Telehealth Model for Human Immunodeficiency Virus Preexposure Prophylaxis Delivery in a rural state. Sex Transm Dis. 2019;46(8):507–12.

    Article  PubMed  Google Scholar 

  23. Rowan SE, Patel RR, Schneider JA, Smith DK. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. Lancet HIV. 2021;8(2):e114–20.

    Article  CAS  PubMed  Google Scholar 

  24. Seidman D, Weber S, Carlson K, Witt J. Family planning providers’ role in offering PrEP to women. Contraception. 2018;97(6):467–70.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Office of Public and Intergovernmental Affairs. https://www.va.gov/opa/pressrel/pressrelease.cfm?id=5467. 2020. VA Video Connect visits increase 1000% during COVID-19 pandemic.

  26. Beste LA, Keddem S, Borgerding J, Lowy E, Gardella C, McFarland L et al. Sexually transmitted infection testing in the national Veterans Health Administration patient cohort during the COVID-19 pandemic. Open Forum Infect Dis. 2022.

Download references

Acknowledgements

This material is the result of work supported with resources and the use of facilities at the U.S. Department of Veterans Affairs MVAHCS Baltimore, MD, USA and the DC VAMC.

Conflict of Interest.

The authors report no real or perceived vested interests related to this article that could be construed as a conflict of interest. The contents of this presentation do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.

Funding

No funding was received for this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Omar Harfouch.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Harfouch, O., Comstock, E., Kaplan, R. et al. Impact of the COVID-19 Pandemic on the PrEP Cascade at Two Veterans Affairs Healthcare Systems. AIDS Behav 28, 1227–1234 (2024). https://doi.org/10.1007/s10461-023-04146-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10461-023-04146-5

Keywords

Navigation